As of 2026-09-23, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 43.40 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 4722.0%.
The range of the Relative Valuation is 28.98 - 72.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 23.0x | 19.5x |
| Forward P/E multiples | 16.5x - 22.0x | 17.0x |
| Fair Price | 28.98 - 72.36 | 43.40 |
| Upside | 3120.0% - 7940.1% | 4722.0% |
| Date | P/E |
| 2026-09-14 | 0.81 |
| 2026-09-11 | 0.10 |
| 2026-09-10 | 0.48 |
| 2026-09-03 | 0.47 |
| 2026-09-02 | 0.58 |
| 2026-08-27 | 0.58 |
| 2026-08-26 | 0.43 |
| 2026-08-20 | 0.33 |
| 2026-08-12 | 0.37 |
| 2026-08-11 | 0.07 |
| 2026-08-10 | 0.04 |
| 2026-08-07 | 0.03 |
| 2026-08-06 | 0.03 |
| 2026-08-05 | 0.03 |
| 2026-07-23 | 0.23 |
| 2026-07-21 | 0.28 |
| 2026-07-16 | 0.37 |
| 2026-07-14 | 0.37 |
| 2026-06-26 | 0.42 |
| 2026-06-25 | 0.38 |
| 2026-06-24 | 0.40 |
| 2026-06-23 | 0.40 |